-SEC Filing
Related Posts
Needham Maintains Buy on PAR Technology, Lowers Price Target to $30
Needham analyst Mayank Tandon maintains PAR Technology (NYSE:PAR) with a Buy and lowers the price target from $53 to $30.
ImmunoPrecise Antibodies Ltd. Announces Voluntary Delisting From TSX Venture Exchange
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ:IPA) (TSXV:IPA) announces that it has applied and has received approval for a voluntary delisting of its common shares from the
Here’s How Much $1,000 Invested In JPMorgan When Jamie Dimon Became Its CEO Would Be Worth Now
JPMorgan Chase & Co.’s (JPM) CEO Jamie Dimon hinted at the company’s Investor Day last Monday that he…